Kim
Abstract
If a patient's type II diabetes is not well controlled with a first-generation sulfonylurea, is it worth trying a newer agent? This study evaluated the impact on glucose control of glipizide, a second-generation sulfonylurea, in 136 …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
If a patient's type II diabetes is not well controlled with a first-generation sulfonylurea, is it worth trying a newer agent? This study evaluated the impact on glucose control of glipizide, a second-generation sulfonylurea, in 136 …
Key concepts: Glipizide, Sulfonylurea, Medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology, Internal medicine, Pharmacology